Viking Therapeutics (NASDAQ: VKTX) soared to center stage earlier this year as a potentially promising player in one of today ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

A RECENT study highlights a concerning link between the use of GLP-1 receptor agonists (GLP-1RA) and inadequate bowel ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

People are more likely to develop type 2 diabetes if they are: Experts with UW Health say it is important to remember the ...

We rate McKesson as a 'Strong Buy' with focus on GLP-1 meds, oncology network, and strong Q2 results driving future growth.

The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted ...

The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

There’s a new warning from the FDA on GLP-1 drugs including Ozempic and Wegovy. In general, when a person prepares for a ...

In October, the FDA removed Mounjaro and Zepbound—the diabetes and obesity GLP-1 drugs made by Eli Lilly—from the shortage ...